Metabolic biology
Insulin resistance and weight loss
If your body responds slowly to dietary change, insulin is often the reason. Insulin resistance is the silent metabolic state that quietly defends weight in millions of adults.
Direct answer
Insulin resistance is a metabolic state where cells respond poorly to insulin, forcing the pancreas to release more. The high circulating insulin promotes fat storage, suppresses fat burning, and intensifies hunger. It is a leading reason "eat less, move more" stops working — and it is one of the strongest indications for GLP-1 therapy.
What is insulin resistance?
Insulin is the hormone that moves glucose into cells. When cells become less responsive — insulin resistance — the pancreas compensates by producing more insulin. The downstream effects:
- Higher fasting and post-meal insulin levels.
- More glucose stored as fat, especially visceral fat.
- Reduced fat mobilization between meals.
- Increased hunger, particularly for carbohydrates.
- Eventual rise in fasting glucose — prediabetes, then type 2 diabetes.
Why does insulin resistance develop?
Insulin resistance is the metabolic consequence of cells being chronically exposed to high insulin and high free fatty acids. Drivers include:
- Excess visceral and ectopic fat (in liver, muscle, pancreas).
- Sedentary lifestyle — exercise is the strongest non-pharmacologic insulin sensitizer.
- Poor sleep and chronic stress.
- High intake of ultra-processed and liquid carbohydrates.
- Genetic predisposition — strong in many ethnic groups.
- Hormonal conditions — PCOS, Cushing's, perimenopause.
Signs you may have insulin resistance
- Waist circumference >40 inches (men) or >35 inches (women).
- Fasting triglycerides ≥150 mg/dL with HDL <40 (men) / <50 (women).
- Acanthosis nigricans (darkened skin patches at neck/armpits).
- Skin tags.
- Afternoon energy crashes and carbohydrate cravings.
- HbA1c ≥5.7%.
- Family history of type 2 diabetes.
Definitive testing: fasting insulin + glucose with HOMA-IR calculation, or 2-hour glucose tolerance test.
Behavioral patterns that worsen insulin resistance
- Long stretches of sitting interrupted by sugar/refined-carb meals.
- Liquid sugar — soda, sweetened coffee, juice.
- Late-night eating — disrupts circadian glucose handling.
- Sleep <6 hours per night.
- Skipping resistance training — muscle is the primary glucose sink.
How GLP-1 medications address insulin resistance
GLP-1 receptor agonists improve every layer of the insulin resistance picture:
- Slowed gastric emptying reduces post-meal glucose spikes.
- Glucose-dependent insulin release reduces excess basal insulin.
- Weight loss — particularly visceral fat reduction — directly improves insulin sensitivity.
- Reduced ectopic fat in liver and muscle.
- Documented improvements in HbA1c, fasting insulin, and HOMA-IR.
Tirzepatide, which acts on both GLP-1 and GIP receptors, often produces additional improvement in insulin sensitivity. See semaglutide vs tirzepatide.
Common misconceptions
Frequently asked questions
Can insulin resistance be reversed?
What is the best test?
Does PCOS cause insulin resistance?
Will GLP-1s cause low blood sugar?
Is metformin the same?
How fast does insulin sensitivity improve?
Educational summary
Insulin resistance quietly defends weight gain, drives type 2 diabetes, and undermines diet attempts. It is identifiable, measurable, and largely reversible. Resistance training, sleep, and reduced refined-carbohydrate intake help. GLP-1 medications produce some of the largest improvements in insulin sensitivity yet seen pharmacologically. Prediabetes · Type 2 diabetes · PCOS.
See if a GLP-1 plan fits you
U.S.-licensed clinicians review every intake. Membership includes the medication, clinician access, and ongoing care.
Choose a planReferences
- Eckel RH et al. The metabolic syndrome. Lancet 2010;375:181–183.
- Wilding JPH et al. STEP 1 trial. NEJM 2021;384:989–1002.
- Frías JP et al. SURPASS-2: Tirzepatide. NEJM 2021;385:503–515.
- DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes. Diabetologia 2010.
Editorial standards
Reviewed against current GLP-1 prescribing labeling, AACE/Endocrine Society obesity guidelines, ADA Standards of Care, and peer-reviewed clinical literature. Educational content — not a substitute for individualized medical advice. See our medical review policy.
